Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin and dexmedetomidine for prevention of postoperative cognitive dysfunction after cardiac surgery
ChiCTR-IPR-17012544Phase 4Recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Aug 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ulinastatin in post-operative cognitive decline (POCD) (4 arms), sponsored by Xuzhou Central Hospital. Primary endpoints: Cognitive function assessment and Brain functional connectivity. Started Aug 2017; status: recruiting.
02
Drugs
dexmedetomidineulinastatin
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR-IPR-17012544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012544.